Valley National Advisers’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Valley National Advisers’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32	Closed	-$1K	–	1230
2023 Q3	$1K	Hold	32	–	–	﹤0.01%	946
2023 Q2	$1K	Hold	32	–	–	﹤0.01%	891
2023 Q1	$1K	Buy	+32	New	+$801	﹤0.01%	820
2022 Q4	–	Sell	-32	Closed	-$1K	–	908
2022 Q3	$1K	Hold	32	–	–	﹤0.01%	842
2022 Q2	$1K	Hold	32	–	–	﹤0.01%	825
2022 Q1	$1K	Sell	32 -1,175	-97%	-$41.5K	﹤0.01%	847
2021 Q4	$53K	Buy	+1,207	New	+$57.1K	0.01%	358

Other funds holding IDNA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Valley National Advisers's IDNA Position: Q4 2023 in Review

Valley National Advisers sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2023, closing a stake of 32 shares — an estimated $1K sold.

Valley National Advisers first reported a position in IDNA in Q4 2021 and held it in 7 quarters. The position peaked at $53K in Q4 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q4 2023.

Valley National Advisers reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2023 after selling out during the quarter.
Valley National Advisers sold 32 iShares Genomics Immunology and Healthcare ETF shares in Q4 2023, an estimated $1K.
Valley National Advisers first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and held it in 7 quarters.
Valley National Advisers's iShares Genomics Immunology and Healthcare ETF position peaked at $53K in Q4 2021.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2023.

Based on Valley National Advisers's 13F filing for Q4 2023, filed 25 Jan 2024.